A UK drug regulator has ruled that a 2017 press release from AstraZeneca was "misleading" as data "had not been presented in a balanced way", following a complaint from a fellow pharma firm.
from Most popular articles from Medical Marketing and Media https://ift.tt/2Le79sE
No comments:
Post a Comment